Late Sleepers and Late Eaters Show Leakier Guts and Fewer Protective Microbes
In 87 adults with obesity, late chronotype and late eating tracked with more metabolic syndrome, a leakier gut, higher inflammation, and fewer SCFA-producing bacteria.
Summary
Researchers studied 87 adults with obesity to see how body-clock timing relates to metabolic health, gut leakiness, and gut bacteria. People who naturally stayed up late (late chronotype) were more likely to have multiple metabolic syndrome features, and late eaters showed a leakier gut on sugar absorption tests. Gut leakiness was linked to higher inflammation, but only in people whose body-clock timing was misaligned. Late sleepers also had fewer bacteria that make short-chain fatty acids, compounds that help keep the gut lining strong. In a follow-up analysis, people whose gut barrier improved after a microbiome-targeting intervention also gained more of these bacteria. The study shows associations, not proof of cause, but it points to the gut as a link between circadian timing and metabolic risk.
Detailed Summary
Metabolic syndrome, a cluster of obesity, insulin resistance, abnormal lipids, and high blood pressure, drives cardiovascular disease, diabetes, and liver disease. Chronic inflammation, often fueled by a leaky gut barrier, is a central mechanism. Animal studies show that disrupting circadian rhythms, through genetics or mistimed eating, alters the microbiome and worsens metabolism, and that stool transfer can even pass the effect to healthy recipients. Whether this holds in humans has been largely untested.
This study analyzed 87 adults with obesity (BMI above 30; mean 37.5) from a randomized clinical trial. Of these, 62 were women and 25 were men, with a mean age of 42.5. Central circadian phenotype was defined by chronotype, and peripheral phenotype by meal timing relative to sleep. Researchers measured cytokines, serum glycans, and metabolites, built a 15-variable composite metabolic-inflammatory (MI) score using Lasso regression, assessed gut permeability with sugar absorption tests (lactulose, mannitol, sucralose), and profiled the gut microbiome.
Most participants were misaligned: 59 (67.8%) had a late chronotype and 66 (75.9%) were late eaters. Late chronotype was associated with high metabolic syndrome burden (71.2% vs. 46.4% in early chronotypes, p=0.025), and late eating showed a borderline association (59.1% vs. 40.9%, p=0.05). The combined trend, from 42.9% in early/early to 72.7% in late/late, was not significant (p=0.07). The MI score distinguished high from low metabolic risk with a cross-validated AUC of 0.918, though this was within the same cohort.
Gut permeability was higher in the high-risk group (24-hour lactulose difference 1.94, p=0.008) and in late eaters (24-hour sucralose difference 0.43, p=0.013). A moderation analysis found that a misaligned circadian phenotype was linked to higher MI scores only in people with elevated permeability (24-hour mannitol excretion above 32.1%; interaction β=0.080, p=0.031).
High metabolic risk was associated with lower microbial diversity (Shannon p=0.009) and depletion of Christensenellaceae and Ruminococcus. Late chronotype was associated with fewer short-chain fatty acid (SCFA)-associated families (Oscillospiraceae, Christensenellaceae, Rikenellaceae) and the mucin-supporting Akkermansiaceae. In an exploratory analysis of the microbial intervention, participants whose aspirin-induced permeability improved showed greater gains in SCFA-associated taxa (aggregate difference 3.30 in log2 fold change, p=0.004 for sucralose; Roseburia difference 4.88, p=0.011 for mannitol).
The findings are correlational and cross-sectional. The sample is modest, and the dataset is from a trial of adults with obesity, so results may not generalize. The mediation models are exploratory and cannot establish causation. Still, the study suggests that aligning sleep and meal timing with the biological clock may support gut barrier function and the microbes that sustain it, and that these effects should be tested in dedicated trials.
Key Findings
- Late chronotype (59 of 87 participants) was linked to high metabolic syndrome burden: 71.2% vs. 46.4% in early chronotypes (p=0.025)
- Late eaters (75.9% of the cohort) were more often in the high-risk group: 59.1% vs. 40.9% (p=0.05); the combined-phenotype trend was not significant (p=0.07)
- A 15-variable metabolic-inflammatory score separated high from low metabolic risk with cross-validated AUC 0.918 and 85.5% accuracy, but only within the same cohort
- High-risk participants had higher 24-hour lactulose excretion (difference 1.94, p=0.008); late eaters had higher 24-hour sucralose excretion (difference 0.43, p=0.013)
- Circadian misalignment was linked to higher metabolic inflammation only when 24-hour mannitol excretion exceeded 32.1% (interaction β=0.080, p=0.031)
- High metabolic risk was associated with lower microbial diversity (Shannon p=0.009), and late chronotype with depletion of Oscillospiraceae, Christensenellaceae, Rikenellaceae, and Akkermansiaceae
- Participants whose gut barrier improved after microbial modulation gained more SCFA-associated taxa (24-hour sucralose aggregate difference 3.30, p=0.004; Roseburia in mannitol 4.88, p=0.011)
Methodology
This was a secondary, largely cross-sectional analysis of 87 adults with obesity enrolled in a randomized clinical trial. Chronotype defined central circadian phenotype and meal timing relative to sleep defined peripheral phenotype. Metabolic inflammation was captured by a Lasso-derived 15-variable composite MI score built from cytokines, glycans, and metabolites. Gut permeability was assessed with urinary sugar probes, and the microbiome was profiled at baseline and after intervention. Statistics included chi-squared and Cochran-Armitage tests, Wilcoxon tests with Benjamini-Hochberg FDR correction, and moderated and sequential mediation models. The mediation models were exploratory.
Study Limitations
The data are observational and exploratory, so they cannot establish causation or the direction of the circadian, gut, and inflammation relationships. The sample is modest, consists of adults with obesity, and includes many subgroup and multi-omic comparisons, and the combined-phenotype trend did not reach significance. The MI score was validated only within the same cohort, and the microbiome intervention analysis was exploratory. Conflicts of interest were not stated in the supplied text.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: